Traditional pharmacotherapy primarily alters synaptic transmission. Neuromodulation platforms (such as rTMS, ECT, and invasive stimulation) primarily alter excitability in specific cortical or subcortical targets. But most existing approaches were not originally designed to deliberately recalibrate the balance and interaction of large-scale networks such as DMN, CEN/FPN, and SN.